(Q47825906)

5 February 2018

review article

1 reference

title

Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell. (English)

1 reference

5 February 2018

0 references

1 reference

Sandhoff K

1

1 reference

5 February 2018

Kolter T

series ordinal

2

1 reference

5 February 2018

Van Echten-Deckert G

series ordinal

3

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

5 February 2018

Annals of the New York Academy of Sciences

published in

1 reference

5 February 2018

volume

845

1 reference

5 February 2018

page(s)

139-151

1 reference

5 February 2018

Glycosphingolipids in cellular interaction, differentiation, and oncogenesis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Signal transduction through lipid second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Sphingolipid biosynthesis in cultured neurons. Down-regulation of serine palmitoyltransferase by sphingoid bases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Lipid recycling between the plasma membrane and intracellular compartments: transport and metabolism of fluorescent sphingomyelin analogues in cultured fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Topology of glycosphingolipid degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Molecular genetics of GM2-gangliosidosis AB variant: a novel mutation and expression in BHK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Over-expression of a functionally active human GM2-activator protein in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

The complete amino-acid sequences of human ganglioside GM2 activator protein and cerebroside sulfate activator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Modulation of phospholipase A2 activity by neutral and anionic glycosphingolipids in monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Gangliosides--a new therapeutic agent against stroke and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

The mannose 6-phosphate receptor and the biogenesis of lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09667.X

10.1111/J.1749-6632.1998.TB09667.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9668348

1 reference

5 February 2018